11. Income Taxes

Provision for Income Taxes

Our provision for income taxes relating to continuing operations consists of the following (in thousands):

December 31,

 

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

 

Current tax provision (benefit)—

Federal

$

235,686

$

170,844

$

(34,722)

State

 

40,486

 

39,897

 

4,222

Total current

 

276,172

 

210,741

 

(30,500)

Deferred tax provision (benefit)—

Federal

 

(3,116)

 

(54,119)

 

81,119

State

 

(2,161)

 

(12,494)

 

14,177

Total deferred

 

(5,277)

 

(66,613)

 

95,296

Provision for income taxes

$

270,895

$

144,128

$

64,796

Rate Reconciliation

The provision for income taxes for the years ended December 31, 2025, 2024 and 2023 resulted in effective tax rates on continuing operations of 20.9%, 21.6% and 16.7%, respectively. The reasons for the differences between these effective tax rates and the federal statutory tax rates are as follows (in thousands, except percentages):

December 31,

2025

2024

2023

Amount

Percent

Amount

Percent

Amount

Percent

Federal statutory tax rate

$

271,625

21.0

%

$

139,978

21.0

%

$

81,521

21.0

%

State and local income taxes, net of federal effect (a)

30,277

2.3

%

21,648

3.2

%

14,537

3.7

%

Tax credits—

 

 

 

R&D tax credit

 

(30,509)

(2.4)

%

 

(23,226)

(3.5)

%

 

(35,033)

(9.0)

%

Other

 

(19)

 

 

Nontaxable or nondeductible items

 

8,186

0.6

%

 

5,328

0.8

%

 

4,489

1.2

%

Other adjustments

 

(8,665)

(0.6)

%

 

400

0.1

%

 

(718)

(0.2)

%

Effective tax rate

$

270,895

20.9

%

$

144,128

21.6

%

$

64,796

16.7

%

(a) State taxes in Virginia, North Carolina, Arizona, New York, Alabama, Tennessee and Utah made up the majority (greater than 50%) of the tax effect of this category in 2025.

In February 2023, we filed amended federal tax returns for 2019 and 2020 requesting refunds primarily from claiming the credit for increasing research activities (the “R&D tax credit”). We previously recorded benefits of $18.9 million for such refund claims in the year 2022. Our refund claims are currently under examination by the Internal Revenue Service (the “IRS”) which, if allowed, would require review and approval by the Joint Committee on Taxation (the “JCT”). We do not expect the conclusion of the IRS examination and JCT review to have a material impact on our financial statements.

In early September 2023, the IRS issued interim guidance addressing, together with other topics, the treatment of research and experimental (“R&E”) expenditures for taxpayers using the percentage of completion method to account for taxable income from long-term contracts. We relied on such guidance for the 2022 tax year, and the resulting reduction in taxable revenue offsets the deferral of tax deductions for R&E expenditures pursuant to the Tax Cuts and Jobs Act (2017) for the 2022 tax year. We filed our 2022 federal tax return in October 2023 requesting a refund of our $107.1 million overpayment, which was received in April 2025. Along with the refund, we received $11.3 million (or $8.9 million, net of tax) of interest income that reduced our provision for income taxes in the first quarter of 2025.

The One Big Beautiful Bill Act was enacted into law on July 4, 2025. The primary provisions of the law impacting us are the (i) reinstatement of immediate expensing of domestic R&E expenditures, together with conforming amendments to the R&D tax credit, (ii) reinstatement of 100% bonus depreciation, and (iii) termination of the energy efficient commercial buildings deduction. However, these provisions did not, and we expect they will not, have a material effect on our operating results, cash flows or financial condition.

Deferred Tax Assets (Liabilities)

Significant components of the deferred tax assets and deferred tax liabilities as reflected on the Consolidated Balance Sheets are as follows (in thousands):

Year Ended

 

December 31,

 

  ​ ​ ​

2025

  ​ ​ ​

2024

 

Deferred tax assets—

Accounts receivable and allowance for credit losses

$

5,097

$

4,139

Stock-based compensation

 

6,977

 

5,329

Accrued liabilities and expenses

 

84,005

 

63,519

Lease liabilities

79,832

57,673

Net operating loss and tax credit carryforwards

 

2,023

 

2,963

Goodwill

17,162

24,592

Intangible assets

19,638

21,075

Other

 

2,214

 

1,685

Subtotal

 

216,948

 

180,975

Valuation allowances

 

(121)

 

(2,751)

Total deferred tax assets

216,827

178,224

Deferred tax liabilities—

Property and equipment

 

(44,621)

 

(29,970)

Lease right-of-use assets

(79,832)

(57,673)

Long-term contracts

 

(4,243)

 

(2,429)

Other

 

(7,884)

 

(4,936)

Total deferred tax liabilities

 

(136,580)

 

(95,008)

Net deferred tax assets

$

80,247

$

83,216

The deferred tax assets and deferred tax liabilities reflected above are included in the Consolidated Balance Sheets as follows (in thousands):

December 31,

  ​ ​ ​

2025

  ​ ​ ​

2024

Deferred tax assets

$

84,139

$

85,441

Deferred tax liabilities

$

3,892

$

2,225

As of December 31, 2025, our deferred tax assets were primarily attributable to accrued liabilities and expenses, goodwill, and intangible assets. All of the net operating loss (“NOL”) and tax credit carryforwards are for various state jurisdictions, the more significant amounts of which begin to expire after the year 2035.

We believe, however, that it is more likely than not that the benefits from the various state NOL and tax credit carryforwards will not all be realized. In recognition of this risk, we have provided a valuation allowance of $0.1 million on the deferred tax assets related to those state NOL and tax credit carryforwards. If or when recognized, the benefits related to any reversal of the valuation allowance on deferred tax assets as of December 31, 2025 will be recognized as a reduction in our provision for income taxes.

Certain of the state NOL and tax credit carryforwards shown in our income tax returns included unrecognized tax benefits. The deferred tax assets recognized for these NOL and tax credits are presented net of unrecognized tax benefits.

Liabilities for Uncertain Tax Positions

A reconciliation of the beginning and ending amount of unrecognized tax benefits, excluding accrued interest and penalties, is as follows (in thousands):

Year Ended December 31,

 

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

 

Balance at beginning of year

$

30,128

$

20,579

$

11,530

Additions based on tax positions related to current year

 

7,889

 

7,591

 

6,370

Additions based on tax positions related to prior years

 

2,244

 

1,958

 

2,723

Reductions for tax positions related to prior years

 

(375)

 

 

(44)

Reductions for lapse of statute of limitations

 

(2,751)

 

 

Balance at end of year

$

37,135

$

30,128

$

20,579

As of December 31, 2025, 2024 and 2023, we had $37.1 million, $30.1 million and $20.6 million, respectively, of unrecognized tax benefits, which if recognized in future periods, would impact our effective tax rates. We also accrued $3.6 million, $1.8 million and $0.6 million for potential interest and penalties related to the unrecognized tax benefits as of December 31, 2025, 2024, and 2023, respectively. We recognize potential interest and penalties related to unrecognized tax benefits in our provision for income taxes.

We are subject to taxation in the federal and various state jurisdictions. As of December 31, 2025, we remain open to IRS examination for the 2022 tax year forward.

State income tax returns are generally subject to examination for a period of three to four years after filing the returns. However, the state impact of any federal audit adjustments and/or amendments remains subject to examination by various states for up to one year after formal notification to the states. As of December 31, 2025, we generally remain open to examination by various state taxing authorities for the 2021 tax year forward.

Historical Timeline

Fiscal YearFiled
2025Feb 19, 2026Showing above
2024Feb 20, 2025
2023Feb 22, 2024
2022Feb 22, 2023
2021Feb 23, 2022
2020Feb 25, 2021
2019Feb 26, 2020
2018Feb 21, 2019
2017Feb 22, 2018
2016Feb 23, 2017
2015Feb 23, 2016

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.